A Caucasian Australian presenting with human T-lymphotropic virus type I associated myelopathy: A case report

被引：1

作者：

Faull M. ^{[1
]}

Panegyres P.K. ^{[1
,2
]}

机构：

[1] Neurodegenerative Disorders Research Pty Ltd., 4 Lawrence Avenue, West Perth, 6005, WA

[2] Neurology Unit, Joondalup Health Campus, Specialists Medical Centre, Suite 102, Shenton Avenue, Joondalup, 6027, WA

来源：

Journal of Medical Case Reports | / 8卷 / 1期

关键词：

Aboriginal Australians; Human T-lymphotropic virus type I; Indigenous populations; Myelopathy;

D O I：

10.1186/1752-1947-8-382

中图分类号：

学科分类号：

摘要：

Introduction: We report the first known case of human T-lymphotropic virus type I associated myelopathy/tropical spastic paraparesis in an Australian Caucasian, a disease reported in Aboriginal and immigrant populations where the virus is often endemic. Case presentation: A 41-year-old Caucasian Australian man had a 3-year background of progressive functional decline from a myelopathy with spastic paraparesis and sphincteric dysfunction. Conclusions: Although studies have shown a very low prevalence of human T-lymphotropic virus type I in the greater Australian population, increased focus on Aboriginal health, and the expanding diversity and integration of the Australian population means that presentation of human T-lymphotropic virus type I-associated disease is likely to increase. © 2014 Faull and Panegyres; licensee BioMed Central Ltd.

引用

共 12 条

[1]

Nakagawa M., Nakahara K., Maruyama Y., Kawabata M., Higuchi I., Kubota H., Izumo S., Arimura K., Osame M., Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis, J Neurovirol, 2, pp. 345-355, (1996)

[2]

Nakamura T., Nishiura Y., Eguchi K., Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Cent Nerv Syst Agents Med Chem, 9, pp. 137-149, (2009)

[3]

Araujo A., Lima M.A., Silva M.T., Human T-lymphotropic virus 1 neurologic disease, Curr Treat Options Neurol, 10, pp. 193-200, (2008)

[4]

Rajabalendaran N., Burns R., Mollison L.C., Blessing W., Kirubakaran M.G., Lindschau P., Tropical spastic paraparesis in an aborigine, Med J Aust, 159, pp. 28-29, (1993)

[5]

May J.T., Stent G., Schnagl R.D., Antibody to human T-cell lymphotropic virus type I in Australian aborigines, Med J Aust, 149, (1988)

[6]

Whyte G.S., Is screening of Australian blood donors for HTLV-I necessary?, Med J Aust, 166, pp. 478-481, (1997)

[7]

Thyagarajan D., Bastian I., Stark R.J., Day B.J., Dax E.M., Gilligan B.S., HTLV-I associated myelopathy in a Seychellois immigrant, Med J Aust, 159, pp. 29-31, (1993)

[8]

Cooper S.A., Schim Van Der Leoff M., Taylor G.P., The neurology of HTLV-1 infection, Pract Neurol, 9, pp. 16-26, (2009)

[9]

Bognato F., Butman J.A., Mora C.A., Gupta S., Yamano Y., Tasciyan T.A., Solomon J.M., Santos W.J., Stone R.D., McFarland H.F., Jacobson S., Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis, J NeuroVirology, 11, pp. 525-534, (2005)

[10]

Puccioni-Sohler M., Gasparetto E., Cabral-Castro M.J., Slatter C., Vidal C.M., Cortes R.D., Rosen B.R., Mainero C., HAM/TSP: Association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings, Arq Neuropsiquiatr, 70, pp. 246-251, (2012)

← 1 2 →